Suppr超能文献

脓毒症——病理生理学与治疗理念

Sepsis-Pathophysiology and Therapeutic Concepts.

作者信息

Jarczak Dominik, Kluge Stefan, Nierhaus Axel

机构信息

Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Front Med (Lausanne). 2021 May 14;8:628302. doi: 10.3389/fmed.2021.628302. eCollection 2021.

Abstract

Sepsis is a life-threatening condition and a global disease burden. Today, the heterogeneous syndrome is defined as severe organ dysfunction caused by a dysregulated host response to infection, with renewed emphasis on immune pathophysiology. Despite all efforts of experimental and clinical research during the last three decades, the ability to positively influence course and outcome of the syndrome remains limited. Evidence-based therapy still consists of basic causal and supportive measures, while adjuvant interventions such as blood purification or targeted immunotherapy largely remain without proof of effectiveness so far. With this review, we aim to provide an overview of sepsis immune pathophysiology, to update the choice of therapeutic approaches targeting different immunological mechanisms in the course of sepsis and septic shock, and to call for a paradigm shift from the pathogen to the host response as a potentially more promising angle.

摘要

脓毒症是一种危及生命的病症,也是一项全球性的疾病负担。如今,这种异质性综合征被定义为由宿主对感染的失调反应所导致的严重器官功能障碍,并重新强调了免疫病理生理学。尽管在过去三十年里进行了大量实验和临床研究,但积极影响该综合征病程和结局的能力仍然有限。循证治疗仍包括基本的病因治疗和支持性措施,而诸如血液净化或靶向免疫治疗等辅助干预措施目前在很大程度上仍未得到有效性的证实。通过这篇综述,我们旨在概述脓毒症的免疫病理生理学,更新针对脓毒症和脓毒性休克病程中不同免疫机制的治疗方法选择,并呼吁从病原体转向宿主反应,将其作为一个可能更有前景的角度进行范式转变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8be2/8160230/b7ae38b6716b/fmed-08-628302-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验